tirzepatide for the treatment of obstructive sleep apnea Diabetes drug resolves in up to 52% patients—is FDA approval in cards? Obstructive sleep apnea with obesity:

Where it works: Hypothalamus: Reduces hunger signals in the appetite control center of the brain Pancreas: Stimulates insulin secretion from beta cells when blood sugar rises Stomach: Slows gastric emptying, keeping you fuller longer Weight loss contribution: GLP-1 activation is responsible for the majority of appetite suppression

Annals of Internal Medicine, 2025 (no statistically significant increase in medullary thyroid or pancreatic cancer)

Enhances weight loss results and promotes overall wellness

We provide the clinical framework and the personalized support necessary to turn metabolic science into real-world results